ArticleBMC oral health2026
Physicochemical stability and bactericidal efficacy of a novel premixed triple antibiotic paste during storage: an in vitro study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTriple antibiotic paste (TAP) is a potent intracanal medicament, but its clinical use is often hindered by preparation variability. A premixed, injectable TAP using a propylene glycol (PG) and carboxymethylcellulose (CMC) vehicle was developed to improve preparation accuracy, handling convenience, and storage stability. This study evaluated the physicochemical stability and bactericidal efficacy of this novel TAP formulation compared to the conventional PG and macrogol (MG) formulation over a 24-week storage period.
methodsTAP (10 mg/mL) was prepared using ciprofloxacin, metronidazole, and minocycline in either PG + MG or PG + CMC vehicles. Formulations were evaluated immediately and after 6, 12, and 24 weeks of storage at 4 °C. Physical stability was assessed by visual inspection of appearance and consistency, while chemical stability was analyzed using UV-visible spectrophotometry across wavelengths of 200-500 nm. Bactericidal activity against Enterococcus faecalis was evaluated using an infected root canal model through bacterial culture and LIVE/DEAD confocal laser scanning microscopy (CLSM).
resultsAlthough both formulations exhibited progressive darkening and increased viscosity during storage, UV spectrophotometry confirmed that antibiotic concentrations remained stable throughout the 24-week period. No culturable bacteria were detected in any TAP-treated groups at any time point. While CLSM analysis showed a significant reduction in bacterial viability compared to controls (p < 0.05), a modest decrease in bactericidal efficacy within dentinal tubules was observed after storage. No significant differences in antimicrobial performance were found between the two formulations (p > 0.05).
conclusionBoth TAP/PG + MG and TAP/PG + CMC maintained chemical stability and effective bactericidal activity for up to 24 weeks. The premixed TAP/PG + CMC formulation provides a clinically practical and standardized alternative to conventional formulations without compromising long-term therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.